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Background: The optimal cutoff of the waist-to-hip ratio (WHR) among Han adults in Xinjiang, which is located in
the center of Asia, is unknown. We aimed to examine the relationship between different WHRs and cardiovascular
risk factors among Han adults in Xinjiang, and determine the optimal cutoff of the WHR.
Methods: The Cardiovascular Risk Survey was conducted from October 2007 to March 2010. A total of 14618
representative participants were selected using a four-stage stratified sampling method. A total of 5757 Han participants
were included in the study. The present statistical analysis was restricted to the 5595 Han subjects who had complete
anthropometric data. The sensitivity, specificity, and distance on the receiver operating characteristic (ROC) curve in
each WHR level were calculated. The shortest distance in the ROC curves was used to determine the optimal cutoff of
the WHR for detecting cardiovascular risk factors.
Results: In women, the WHR was positively associated with systolic blood pressure, diastolic blood pressure, and
serum concentrations of serum total cholesterol. The prevalence of hypertension and hypertriglyceridemia increased
as the WHR increased. The same results were not observed among men. The optimal WHR cutoffs for predicting
hypertension, diabetes, dyslipidemia and ≥ two of these risk factors for Han adults in Xinjiang were 0.92, 0.92, 0.91, 0.92
in men and 0.88, 0.89, 0.88, 0.89 in women, respectively.
Conclusions: Higher cutoffs for the WHR are required in the identification of Han adults aged ≥ 35 years with a high
risk of cardiovascular diseases in Xinjiang.
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Obesity is becoming an epidemic health problem world-
wide in developed and developing countries [1]. The
prevalence of obesity in adults increased by nearly 50%
from the 1980s to 1990s [2]. Currently, approximately 70%
of adults are classified as overweight or obese compared
with a prevalence of 25% for obesity 40 years ago [3,4].
Overweight and obesity represent a rapidly growing threat
to the health of populations in an increasing number of
countries [1].* Correspondence: myt-xj@163.com
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unless otherwise stated.Obesity has also been shown to be associated with
numerous cardiovascular disease (CVD) risk factors,
such as hypertension, dyslipidemia, type 2 diabetes, and
insulin resistance [5-8]. A simple anthropometric measure-
ment as an indicator for obesity related to cardiovascular
risk factors is of interest for use in public health actions.
Many studies have reported that body fat distribution is a
more powerful predictor than body mass index (BMI) for
risk factors, diseases, and mortality [9,10]. In particular,
increased visceral or abdominal adipose tissue is more
strongly associated with metabolic and CVD risk and a
variety of chronic diseases [11,12]. BMI is consistently
associated with an increased risk of CVD and type 2
diabetes [13], but this measurement does not accounthis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Li et al. BMC Cardiovascular Disorders 2014, 14:93 Page 2 of 8
http://www.biomedcentral.com/1471-2261/14/93for variation in body fat distribution and abdominal fat
mass, which can greatly differ across populations and
substantially vary within a narrow range of BMI [14].
Excess intra-abdominal fat is associated with a greater
risk of obesity-related morbidity than overall adiposity
[15,16]. Several studies in adults have reported a stronger
positive association between cardiovascular risk factors
and abdominal adiposity than overall adiposity [17,18].
Therefore, central obesity indices are slightly better
than BMI regarding an association with cardiovascular
risk factors [19,20].
The waist-to-hip ratio (WHR), a simple indicator for
central obesity, has also been reported as a good surro-
gate for central obesity and is associated with the risk
of CVD [20-25]. Similar to BMI, the relationship of
WHR and related health risks is affected by age, sex,
and regional differences. Therefore, the optimal cutoff
values for WHR in detection of cardiovascular risks are
likely to be different among different populations [26].
In 2002, a study in 11 provinces of China suggested
that the optimal cutoffs of WHR in men and women
were 0.90 and 0.80, respectively [27]. A study in Thailand
suggested that the optimal cutoffs of WHR for diabetes,
hypertension, and dyslipidemia were 0.89–0.91 in men
and 0.85–0.88 in women [20]. For Chinese in Hong Kong,
the optimal cutoff of WHR is 0.85 in men and 0.80 in
women [22]. A previous study assessed optimal cutoffs for
WHR in terms of association with diabetes, hypertension,
and dyslipidemia in Taiwan [23]. The optimal cutoffs were
0.87–0.90 and 0.78–0.83 for WHR in men and women,
respectively. In Jordanian adults, the WHR cutoff values
vary from 0.88 to 0.90 in men and from 80.0 to 0.83 in
women [24]. Therefore, applying the regional optimal
cutoff of WHR for screening populations with a high
risk of CVD is important.
Xinjiang Uighur Autonomous Region, which is located
in the center of Asia and northwest of China, has a
unique cultural and geographical background. The total
Han population was 7.5 million in 2000, and 40.61% of
the total population is in Xinjiang. The optimal cutoff of
WHR associated with cardiovascular risk factors among
Han adults in Xinjiang remains unknown. Therefore, in
the present study, we examined the relationship between
WHR and cardiovascular risk factors. We also determined
the optimal cutoff points of WHR for detecting cardiovas-
cular risk factors among Han adults in Xinjiang.
Methods
Ethics statement
The present study was approved by the Ethics Committee
of the First Affiliated Hospital of Xinjiang Medical Univer-
sity and was conducted according to the standards of the
Declaration of Helsinki. Written, informed consent was
obtained from the participants.Sample design
All of the participants were selected from the Cardiovas-
cular Risk Survey (CRS) study. The details of the study
population and methods have been described previously
[28,29]. Briefly, the CRS study used a four-stage stratified
sampling method to select a representative sample of the
general population in Xinjiang, northwest of China. The
research sites included Urumqi City, Kelamayi City,
Fukang City, Turpan Prefecture, Hetian Prefecture, and
Yili Prefecture. The time period of the study was from
October 2007 to March 2010. The selections made from
sampling units were based on geographic area, sex, and
age groups using household registries. The four-stage
stratified sampling method was as follows. In stage one,
according to population census data of Xinjiang in 2000,
the areas mentioned above were selected based on
population, ethnicity, geography, economic and cultural
development level. In stage two, according to the ethnic
aggregation status, one district or county was randomly
selected from an area with a dominant Uighur population.
In stage three, one community or town (village) was
randomly selected from each district or county. In stage
four, subjects aged older than 35 years were randomly
selected from each community or town (village) as research
subjects. Staff conducted surveys in households and
administered questionnaires. The questionnaires included
demographic, socioeconomic, and dietary information, and
the medical history of each participant. In total, the CRS
included 14,618 participants (5757 Hans, 4767 Uighurs,
and 4094 Kazakhs).
A total of 5595 Han subjects with complete anthropo-
metric data were enrolled in the present study. A total
of 2700 subjects were men and 2895 subjects were
women. The age of the subjects ranged from 35 to
88 years old, with a mean ± SD age of 52.52 ± 12.70 years
(men, 52.31 ± 13.29 years; women, 52.72 ± 12.12 years).
Anthropometric measurements
Data collection involved one visit in the participants’
residential areas. During the examinations, a standard
questionnaire assessing demographic information and
medical history was collected by trained research staff. A
waist circumference measurement was taken at the end of
normal expiration and to the nearest 0.1 cm, measuring
from the narrowest point between the lower borders of
the rib cage and the iliac crest. Hip circumference was
measured to the nearest 0.1 cm, as recommended by the
World Health Organization (WHO) [30]. The WHR was
calculated.
Laboratory methods
Blood samples were obtained from an antecubital vein
into Vacutainer tubes containing EDTA in the morning
after an overnight fasting period. Blood samples were
























Men 363 586 423 244 253 200 201 272 101 43 14 2700
Women 332 594 369 329 314 316 328 212 71 27 3 2895
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was transferred to separate labeled tubes and transported
immediately on dry ice at prearranged intervals to the
Xinjiang coronary artery disease VIP laboratory. Serum
concentrations of serum total cholesterol, triglycerides,
low-density lipoprotein (LDL), high-density lipoprotein
(HDL), and fasting glucose were measured by the Clinical
Laboratory Department of the First Affiliated Hospital of
Xinjiang Medical University with a biochemical analyzer
(Dimension AR/AVL Clinical Chemistry System, Newark,
NJ, USA) [28,29].Blood pressure measurement
A mercury sphygmomanometer was used to measure blood
pressure in the sitting position after a 10-minute rest
period. During the 30 minutes preceding measurement,
the subjects were required to refrain from smoking or
consuming caffeine. The appearance of the first sound
was used to define systolic blood pressure, and the dis-
appearance of sound was used to define diastolic blood
pressure [31]. Two readings each of systolic and diastolic
blood pressures were recorded, and the average of each
measurement was used for data analysis. If the first two
measurements differed by more than 5 mmHg, additional
readings were taken.Table 2 Sample size of cardiovascular risk factors in men and





Blood pressure(n) 27 74 225
Fasting glucose(n) 25 73 226
Total cholesterol(n) 25 73 226
LDL cholesterol(n) 27 74 226
HDL cholesterol(n) 27 74 226
Triglycerides(n) 25 73 226
Women
Blood pressure(n) 122 319 602
Fasting glucose(n) 117 310 590
Total cholesterol(n) 117 310 590
LDL cholesterol(n) 120 315 587
HDL cholesterol(n) 120 315 589
Triglycerides(n) 117 310 590Definition of risk factors
Hypertension was defined as self-reported use of antihy-
pertensive medication within the past 2 weeks or an
average systolic blood pressure ≥140 mm Hg, an average
diastolic blood pressure ≥90 mm Hg, or both.
Diabetes was defined as fasting plasma glucose ≥7.0
mmol/L, use of insulin or oral hypoglycemic agents, or a
self-reported history of diabetes.
Total cholesterol concentrations >6.22 mmol/L (240 mg/
dl) were defined as hypercholesterolemia. Triglyceride
concentrations >2.26 mmol/L (200 mg/dl) were defined as
hypertriglyceridemia. LDL cholesterol concentrations >4.14
mmol/L (160 mg/dl) were defined as high LDL cholesterol.
HDL cholesterol concentrations <1.04 mmol/L (40 mg/dl)
were defined as low HDL cholesterol [27]. Dyslipidemia
was defined as any one of the four lipids abnormalities
mentioned above or self-reported use of antihyperlipidemic
medication.
Statistical analysis
Statistical analysis was conducted using SPSS version
16.0 for Windows (SPSS Inc., Chicago, IL, USA). Continu-
ous variables are expressed as sex-specific means and
standard deviations, and discrete variables are expressed
as sex-specific proportions. Analysis of variance was used







WHR ≥ 1.00 Total
656 839 530 304 2655
648 834 513 301 2620
648 834 513 300 2619
645 815 510 296 2593
645 815 510 297 2594
648 834 513 300 2619
649 453 311 399 2855
639 452 311 397 2816
639 452 311 398 2817
643 446 307 381 2799
643 446 307 383 2803
639 452 311 398 2817
Table 3 Age-standardized CVD risk factors in men by WHR category










WHR ≥ 1.00 P values
Population distribution n(%) 28(1.04%) 75(2.78%) 232(8.59%) 670(24.81%) 855(31.67%) 531(19.67%) 309(11.44%)
Systolic blood pressure(mmHg) 134.70 ± 19.19 128.97 ± 15.08 128.44 ± 18.61 131.57 ± 17.34 134.45 ± 18.02 137.66 ± 18.48 141.28 ± 21.35 <0.001
Diastolic blood pressure(mmHg) 86.19 ± 12.27 83.12 ± 15.31 82.85 ± 15.02 85.86 ± 14.42 87.42 ± 14.27 89.70 ± 15.90 91.06 ± 16.44 <0.001
Total cholesterol(mmol/L) 4.38 ± 0.68 4.53 ± 1.08 4.37 ± 1.01 4.63 ± 1.09 4.77 ± 1.10 4.72 ± 1.07 4.68 ± 0.92 <0.001
HDL cholesterol(mmol/L) 1.17 ± 0.42 1.30 ± 0.44 1.26 ± 0.39 1.24 ± 0.45 1.24 ± 0.47 1.21 ± 0.42 1.26 ± 0.43 0.473
LDL cholesterol(mmol/L) 2.59 ± 0.81 2.74 ± 0.68 2.80 ± 0.87 2.83 ± 0.88 2.88 ± 0.91 2.89 ± 0.92 2.88 ± 0.91 0.326
Triglycerides(mmol/L) 1.51 ± 1.02 1.36 ± 0.96 1.40 ± 1.14 1.78 ± 1.59 2.16 ± 1.78 2.12 ± 1.75 2.10 ± 1.35 <0.001
Fasting glucose(mmol/L) 5.30 ± 1.12 5.12 ± 1.52 5.25 ± 2.39 5.45 ± 1.69 5.40 ± 1.63 5.57 ± 2.41 5.80 ± 2.21 0.011
Data are presented as mean ± SD or n(%).
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statistically significant difference. Age standardization
was performed by the direct method by using the Han
population according to the population census data of
Xinjiang in 2000 [32] as the standard population. The
sensitivity and specificity of each WHR level for the
detection of hypertension, dyslipidemia, diabetes, and two
or more of these risk factors were calculated by creating
dichotomous variables for each WHR value. Additionally,
the distance on the receiver operating characteristic (ROC)
curve of each WHR value was calculated as the square root
of [(1 − sensitivity)2 + (1 − specificity)2]. The WHR value
with the shortest distance on the ROC curve was consid-
ered in the determination of optimal cutoffs. The overall
performance of the WHR test for detecting cardiovascular
risk factors was assessed by computing the area under the
curve (AUC). An AUC of 1 is considered to have perfect
discriminatory power, and an AUC of 0.5 suggests that the
discriminatory power is no better than chance.
Results
Baseline characteristics of the distribution of age categor-
ies and sample size of cardiovascular risk factors by WHR
category between sexes are shown in Tables 1 and 2.Table 4 Age-standardized CVD risk factors in women by WHR




Population distribution n(%) 124(4.28%) 325(11.23%) 608(21.00%
Systolic blood pressure(mmHg) 119.48 ± 18.42 119.76 ± 17.59 125.23 ± 18.4
Diastolic blood pressure(mmHg) 78.27 ± 15.33 78.89 ± 15.13 80.81 ± 14.57
Total cholesterol(mmol/L) 4.28 ± 1.30 4.48 ± 0.94 4.61 ± 1.04
HDL cholesterol(mmol/L) 1.28 ± 0.43 1.28 ± 0.43 1.30 ± 0.50
LDL cholesterol(mmol/L) 2.83 ± 1.03 2.86 ± 0.93 2.87 ± 0.96
Triglycerides(mmol/L) 1.16 ± 1.67 1.16 ± 0.78 1.30 ± 0.87
Fasting glucose(mmol/L) 4.83 ± 1.47 5.03 ± 1.33 5.07 ± 1.62
Data are presented as mean ± SD or n(%).Compared with men, WHR levels were higher, with
higher systolic blood pressure, diastolic blood pressure
and serum total cholesterol concentrations in women.
We did not notice any trends in men (Tables 3 and 4).
In women, the prevalence of hypertension and hyper-
triglyceridemia increased as the WHR increased. The
prevalence of diabetes, hypercholesterolemia, high LDL
cholesterol, and low HDL cholesterol did not show any
significant relationship with WHR. We did not observe
any relationships with these variables and WHR in men
(Tables 5 and 6).
The population distribution of each WHR level, and
the sensitivity, specificity, and distance on the ROC
curve for the detection of hypertension, dyslipidemia,
diabetes, and ≥ two of these risk factors for men and
women are shown in Tables 7 and 8, respectively. In
men, the cutoff for dyslipidemia was 0.91. The shortest
distances on the ROC curve of hypertension, diabetes
and ≥ two of these risk factors were the same. A WHR of
0.92 appeared to be the optimal WHR cutoff in men. In
women, the shortest distance on the ROC curve for
hypertension and dyslipidemia was 0.88. The shortest
distance on the ROC curve for diabetes and ≥ two of







WHR ≥ 1.00 P values
) 658(22.73%) 462(15.96%) 315(10.88%) 403(13.92%)
5 131.4 ± 21.50 134.6 ± 19.59 136.41 ± 20.24 143.39 ± 19.22 <0.001
83.08 ± 16.00 84.22 ± 15.69 84.90 ± 16.40 86.17 ± 15.40 <0.001
4.70 ± 1.18 4.74 ± 1.05 4.85 ± 1.00 4.94 ± 1.10 <0.001
1.26 ± 0.46 1.25 ± 0.40 1.26 ± 0.44 1.25 ± 0.56 0.54
2.88 ± 0.92 2.91 ± 0.91 2.88 ± 0.95 2.90 ± 0.87 0.976
1.48 ± 1.08 1.64 ± 1.42 1.61 ± 1.16 1.83 ± 1.16 <0.001
5.19 ± 1.39 5.32 ± 1.54 5.16 ± 1.62 5.62 ± 1.77 <0.001
Table 5 Age-standardized prevalence of risk factors in men by WHR category










WHR ≥ 1.00 P values
Hypertension 29.6%(14) 29.7%(25) 27.6%(67) 36.3%(243) 39.2%(334) 48.7%(259) 55.6%(174) <0.001
Diabetes 8%(6) 5.5%(8) 5.8%(17) 9%(63) 9.1%(81) 10.1%(57) 12.3%(49) 0.205
Hypercholesterolemia 16%(9) 26%(20) 20.8%(52) 25.9%(177) 32.1%(274) 29.6%(159) 27.7%(97) 0.011
High LDL cholesterol 22.2%(11) 32.4%(26) 36.3%(88) 36.9%(242) 38.7%(318) 38.2%(203) 38.9%(119) 0.605
Low HDL cholesterol 40.7%(16) 28.4%(23) 28.3%(72) 34.7%(229) 35.3%(291) 37.6%(211) 31.6%(103) 0.169
Hypertriglyceridemia 32%(13) 23.3%(19) 22.6%(54) 35.2%(232) 49%(504) 52%(270) 52.7%(177) <0.001
Data are presented as %(n).
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Figure 1. The AUCs of each cardiovascular risk factor in
men and women are shown in Table 9. We found that
the discriminatory power of WHR for cardiovascular risk
factors was slightly better in women than in men.
Discussion
Obesity is becoming an epidemic health problem world-
wide in developed and developing countries [1]. In 1998,
the WHO announced that the cutoffs of WHR used to
define central adiposity were 0.90 in men and 0.85 in
women [14]. According to the WHO cutoffs for the
designation of central adiposity based on Western pop-
ulations, the present study showed that 62.8% of male
Han adults had a WHR ≥0.90 and 63.5% of the female
Han adults had a WHR ≥0.85.
Obesity, especially abdominal adiposity, has been shown
to increase the risk of CVD through many cardiovascular
risk factors, including hypertension, diabetes, and dyslipid-
emia [5-8]. WHR, a simple indicator for central obesity,
has also been reported as a discriminator for identifying
individuals with CVD risk factors [20,25]. Despite the fact
that a close relationship is apparent between abdominal
adiposity and the risk of CVD, the current WHR cutoffs
suggested by the WHO are not based on associations
with CVD risk factors, but rather on their correlation
with corresponding values of BMI. In the Asian population,
which has a predisposition to central obesity and related
increased risk in CVD, the WHR had been set with dif-
ferent cutoff points across regions [20,22-24]. Therefore,Table 6 Age-standardized prevalence of risk factors in wome
WHR < 0.75 0.75 ≤
WHR < 0.80
0.80 ≤
WHR < 0.85 W
Hypertension 18.9%(29) 20.1%(73) 27.7%(162)
Diabetes 3.4%(7) 4.2%(13) 3.4%(27)
Hypercholesterolemia 20.5%(31) 20%(68) 26.3%(153)
High LDL cholesterol 33.3%(48) 34%(110) 35.8%(214)
Low HDL cholesterol 31.7%(51) 30.2%(90) 29%(178)
Hypertriglyceridemia 12%(22) 15.2%(54) 18.5%(106)
Data are presented as %(n).determining the optimal cutoff of WHR based on associa-
tions with CVD risk factors among Han adults in Xinjiang
to allow effective screening is important.
In the present study, based on the sensitivity, specificity,
and ROC calculations, the optimal cutoffs of WHR for
Han men and women in Xinjiang were 0.92 and 0.89,
respectively. We found that although the Han population
in Xinjiang belonged to the Asian population, the optimal
cutoffs of WHR for CVD risk factors among Han adults
in Xinjiang were higher than those in some other regions
of Asia, such as Hong Kong [22], Taiwan [23], Thailand
[20], and Jordan [24]. The reasons why there are higher
optimal cutoffs of WHR among Han adults in Xinjiang
are unclear. Possible reasons may be associated with
differences in diet, climate, and some important genes
that regulate body fat distribution. First, the primary reason
may be a difference in diet in Han adults compared with
Asian populations in other regions. The Han population in
Xinjiang consumes more pasta, meat, and milk products
than Asian populations in other regions. Second, a
characteristic feature of the climate in Xinjiang is that
the temperature difference during day and night is
considerable, and winter is extremely cold. Therefore,
subcutaneous fat thickness in the Han population in
Xinjiang may be thicker than other populations for
adaptation to the external environment. Third, certain
genes that regulate body fat distribution may be different
in different populations, so that body fat is more likely
to accumulate in the abdomen [33-35]. In addition, the







WHR ≥ 1.00 P value
35.6%(241) 41.9%(197) 47.3%(149) 58.4%(230) <0.001
6.7%(45) 9.1%(40) 6.1%(18) 13.4%(57) <0.001
30.2%(197) 30.8%(143) 37.3%(113) 37.7%(168) <0.001
36.7%(242) 37.9%(171) 35.8%(115) 38.6%(159) 0 .849
31.7%(203) 30.9%(144) 32.6%(98) 34.5%(144) 0 .717
26.8%(175) 31.6%(146) 32.2%(94) 44.5%(182) <0.001
Table 7 Sensitivity(sens), specificity(spec), and distance in the ROC curve for WHR cutoffs in men
Hypertension Diabetes Dyslipidemia ≥2 risk factors
WHR n Sens % Spec % Distance in
ROC curve
Sens % Spec % Distance in
ROC curve
Sens % Spec % Distance in
ROC curve
Sens % Spec % Distance in
ROC curve
0.80 21 97.00 4.90 0.95 97.50 4.20 0.96 96.90 5.30 0.95 98.50 5.10 0.95
0.81 29 96.40 6.10 0.94 96.70 5.20 0.95 96.00 6.60 0.93 98.30 6.30 0.94
0.82 33 95.60 7.50 0.93 94.60 6.30 0.94 95.20 8.30 0.92 97.20 7.40 0.93
0.83 49 94.00 9.50 0.91 94.20 8.30 0.92 93.70 10.80 0.89 96.10 9.60 0.90
0.84 48 93.10 11.80 0.88 93.40 10.20 0.90 92.60 13.80 0.87 95.30 11.80 0.88
0.85 71 91.30 15.00 0.85 92.10 13.00 0.87 90.60 17.40 0.83 94.30 15.20 0.85
0.86 84 88.60 18.40 0.82 89.70 16.10 0.85 88.00 20.90 0.80 92.40 18.70 0.82
0.87 138 84.80 24.20 0.77 86.80 21.10 0.80 83.30 26.00 0.76 88.90 24.10 0.77
0.88 137 81.00 30.30 0.72 82.20 26.50 0.76 78.10 31.60 0.72 84.80 29.70 0.72
0.89 148 76.30 36.20 0.68 75.60 31.70 0.73 73.20 37.50 0.68 79.80 35.30 0.68
0.90 179 64.80 42.20 0.68 68.20 38.50 0.69 66.00 44.10 0.65 71.40 41.50 0.65
0.91 162 63.00 48.30 0.64 63.60 44.40 0.66 59.90 49.40 0.65 66.30 47.60 0.62
0.92 151 57.00 54.10 0.63 59.10 50.30 0.64 53.30 53.80 0.66 60.50 53.40 0.61
0.93 164 51.40 60.40 0.63 51.20 56.30 0.66 46.60 58.90 0.67 53.10 59.10 0.62
0.94 187 44.30 67.50 0.64 45.00 63.40 0.66 39.50 65.40 0.70 47.00 66.70 0.63
0.95 144 38.30 75.00 0.67 36.80 70.30 0.70 32.50 72.60 0.73 39.90 73.60 0.66
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and physical activity. We also found that the optimal
cutoffs of WHR for detecting cardiovascular risk factors
were higher than WHO cutoffs for the definition of
central adiposity. Apart from ethnic and regional differ-
ences, the main reason for this difference may be thatTable 8 Sensitivity(sens), specificity(spec), and distance in the
Hypertension Diabetes
WHR n Sens % Spec % Distance in
ROC curve
Sens % Spec % Distanc
ROC cu
0.80 92 91.30 20.70 0.80 91.20 16.50 0.84
0.81 76 88.60 23.30 0.78 90.20 19.30 0.81
0.82 122 85.80 28.50 0.73 88.60 23.60 0.77
0.83 139 82.40 34.10 0.68 86.50 28.60 0.73
0.84 142 78.80 39.80 0.64 82.40 33.50 0.69
0.85 117 75.50 44.20 0.61 80.80 37.80 0.65
0.86 114 72.20 48.60 0.58 78.80 41.90 0.62
0.87 138 67.10 53.20 0.57 73.10 46.60 0.60
0.88 151 62.20 58.60 0.56 67.90 51.70 0.58
0.89 126 57.70 62.40 0.57 64.20 55.90 0.57
0.90 127 53.70 67.40 0.57 57.00 60.30 0.59
0.91 94 49.30 69.90 0.59 51.30 63.40 0.61
0.92 110 45.60 73.80 0.60 47.70 67.20 0.62
0.93 80 42.40 76.30 0.62 42.50 69.80 0.65
0.94 84 39.10 78.90 0.64 40.40 72.80 0.66
0.95 94 35.90 81.80 0.67 37.30 75.90 0.67the definition of central adiposity was not based on
associations with CVD risk factors. Moreover, the WHO
definition was published nearly a decade ago, and the
prevalence of obesity among adults increased by nearly 50%
during the 1980s and 1990s, and the current prevalence of
obesity is nearly three higher compared with 40 years ago.ROC curve for WHR cutoffs in women
Dyslipidemia ≥2 risk factors
e in
rve
Sens % Spec % Distance in
ROC curve
Sens % Spec % Distance in
ROC curve
85.90 17.90 0.83 93.70 19.00 0.81
83.70 21.10 0.81 91.20 21.80 0.79
79.90 25.70 0.77 89.40 26.70 0.74
76.00 31.30 0.73 86.70 32.10 0.69
71.80 37.00 0.69 83.60 37.60 0.65
68.00 41.30 0.67 80.30 41.80 0.61
64.20 45.30 0.65 77.20 46.00 0.59
59.90 50.50 0.64 72.40 50.90 0.56
54.70 55.80 0.63 67.70 56.10 0.55
50.00 59.40 0.64 63.00 60.10 0.54
45.30 64.00 0.65 58.00 64.50 0.55
41.60 67.00 0.67 54.20 67.70 0.56
37.20 70.10 0.70 50.50 71.50 0.57
34.50 73.20 0.71 46.80 74.00 0.59
31.50 76.10 0.73 44.40 77.10 0.60
28.10 78.60 0.75 41.00 79.90 0.62
Figure 1 ROC curves to detect CVD risk factors by sex. (A) ROC curves for both men and women for the detection of hypertension, (B)
diabetes, (C) dyslipidemia and (D)≥ 2 of these risk factors.
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http://www.biomedcentral.com/1471-2261/14/93Therefore, as the prevalence of obesity worldwide increases
[36,37], WHR cutoffs may have some minor changes
compared with definitions made 15 years ago.
In addition, we also found that in men with a WHR <0.75,
the prevalence of low HDL cholesterol was up to 40%,
which was significantly higher than that in men with
other WHR levels. The prevalence of diabetes and
hypertriglyceridemia also appeared to be higher in men
with a WHR <0.75. These findings could be attributed
to the following factors. First, the number of subjects in
men with a WHR <0.75 (only 28 subjects) was less than
that in other groups. Therefore, the power of the data
set may be low. Second, most of subjects in men with a
WHR <0.75 were likely to suffer from type 1 diabetes,
glucose metabolism disorders, and other diseases, which
may result in dyslipidemia. Third, the majority of subjectsTable 9 AUC of each cardiovascular risk factor in men
and women
AUC(95% CI) in men AUC(95% CI) in women
Hypertension 0.590(0.568, 0.612) 0.645(0.624, 0.665)
Diabetes 0.561(0.524, 0.599) 0.629(0.588, 0.669)
Dyslipidemia 0.553(0.530, 0.576) 0.562(0.540, 0.583)
≥2 risk factors 0.606(0.583, 0.630) 0.665(0.642, 0.688)in men with a WHR <0.75 may have a history of long-
term heavy smoking, excessive drinking, and malnutrition.
The present study has several strengths. This is the first
representative sample of general Han adults in Xinjiang.
Therefore, these results can be generalized to adults of the
Han population aged older than 35 years. Additionally, we
provided information for a wide range of WHR values,
stratified by sex. Future studies can use these WHR
cutoffs to further study the associated risk factors and
intervention of overweight and obesity in a representative
sample of the Han adult population in Xinjiang. There
are also limitations of the present study. First, our study
was a cross-sectional design. Therefore, cause-effect tem-
porality could not be readily evaluated. Second, because
of a lack of information, we could not exclude potential
confounding effects from medications, such as glucocor-
ticoids, or from the presence of liver cirrhosis, thyroid
disease, ascites, malnutrition, and cancer. Third, in data
analysis, we excluded outliers and missing values in blood
specimens caused by systemic factors, which can lead to
incomplete data of blood samples, and affect the results.
Conclusions
This study showed WHR values of 0.92 in men and 0.89
in women as the optimal cutoffs in the identification of
Li et al. BMC Cardiovascular Disorders 2014, 14:93 Page 8 of 8
http://www.biomedcentral.com/1471-2261/14/93Han adults at a high risk of CVD. This study has added
further important knowledge on the relationship between
WHR values and cardiovascular risk factors.
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